
AnPac Bio-Medical Science Co., Ltd. ANPC
Annual report 2022
added 12-27-2025
AnPac Bio-Medical Science Co., Ltd. Gross Profit 2011-2026 | ANPC
Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.
Calculation formula:Importance for business:
Gross Profit = Revenue – Cost of Goods Sold (COGS)
Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
- Raw materials and supplies
- Wages of production personnel
- Depreciation of equipment
- Transportation and warehousing costs (if directly related to production)
- Assessing core business profitability
If gross profit is declining, it may indicate rising production costs or falling sales. - Financial planning
Gross profit is the basis for calculating other key metrics, such as operating and net profit. - Benchmarking against competitors
Gross profit analysis helps compare the efficiency of different companies within the same industry. - Insights into pricing effectiveness
If gross profit is low, the company may be pricing too low or failing to control costs effectively.
- Increase in raw material and supply costs
- Rising production expenses
- Price reductions due to competition
- Decrease in sales volume
- Currency exchange rate fluctuations (for imports/exports)
Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.
Annual Gross Profit AnPac Bio-Medical Science Co., Ltd.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.34 M | 12.3 M | 12.9 M | 4.8 M | 4.58 M | 1.73 M | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 12.9 M | 1.73 M | 7.43 M |
Gross Profit of other stocks in the Biotechnology industry
| Issuer | Gross Profit | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
180 M | - | 2.43 % | $ 254 M | ||
|
Acer Therapeutics
ACER
|
1.27 M | - | 2.71 % | $ 14 M | ||
|
Acorda Therapeutics
ACOR
|
119 M | - | -24.86 % | $ 820 K | ||
|
ADMA Biologics
ADMA
|
293 M | $ 16.45 | 0.43 % | $ 3.92 B | ||
|
AgeX Therapeutics
AGE
|
102 K | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.52 B | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
-104 K | $ 0.83 | 4.23 % | $ 4.53 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
12.1 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-428 K | - | -18.52 % | $ 27.3 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-523 K | - | -11.43 % | $ 502 K | ||
|
ANI Pharmaceuticals
ANIP
|
143 M | $ 76.75 | 0.85 % | $ 1.48 B | ||
|
Aravive
ARAV
|
5.68 K | - | -13.39 % | $ 1.45 M | ||
|
Adverum Biotechnologies
ADVM
|
2.32 M | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
774 M | - | - | - | ||
|
Athersys
ATHX
|
1.44 M | - | 3.77 % | $ 22.4 M | ||
|
AVEO Pharmaceuticals
AVEO
|
4.77 M | - | - | $ 521 M | ||
|
BridgeBio Pharma
BBIO
|
38.1 M | $ 66.98 | 3.8 % | $ 12.8 B | ||
|
BioDelivery Sciences International
BDSI
|
14 M | - | -4.8 % | $ 255 M | ||
|
Acasti Pharma
ACST
|
-32.3 K | - | 4.01 % | $ 150 M | ||
|
BeiGene, Ltd.
BGNE
|
4.67 B | - | 0.49 % | $ 251 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
500 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
53.8 M | - | -7.31 % | $ 87 M | ||
|
CureVac N.V.
CVAC
|
-10.6 M | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
4.73 M | - | 5.93 % | $ 314 M | ||
|
BioLineRx Ltd.
BLRX
|
19.7 M | $ 2.88 | 2.51 % | $ 908 M | ||
|
BioMarin Pharmaceutical
BMRN
|
1.34 B | $ 60.75 | 3.79 % | $ 11.7 B | ||
|
AIkido Pharma
AIKI
|
10 K | - | 1.93 % | $ 17.4 M | ||
|
Agenus
AGEN
|
-18.3 M | $ 3.24 | 1.73 % | $ 1.16 M | ||
|
Cabaletta Bio
CABA
|
0.006 | $ 3.41 | 4.77 % | $ 3.98 M | ||
|
Ayala Pharmaceuticals
AYLA
|
90 K | - | - | $ 7.46 M | ||
|
Capricor Therapeutics
CAPR
|
310 | $ 25.71 | -0.5 % | $ 688 M | ||
|
Agios Pharmaceuticals
AGIO
|
117 M | $ 28.49 | 0.04 % | $ 1.65 B | ||
|
Avid Bioservices
CDMO
|
7.32 M | - | - | $ 789 M |